Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

February 17, 2021February 17, 2021

More Barriers, Lower Socioeconomic Status Tied to Less Exercise Therapy

News

People with pulmonary hypertension are less likely to be referred to exercise therapy if they are of lower socioeconomic status or perceive more barriers to accessing such therapy, a ... Read more

February 3, 2021February 3, 2021

Pemziviptadil Shows Promise in Small Clinical Trial

News, PAH News

PhaseBio Pharmaceuticals‘s investigational therapy pemziviptadil (PB1046) showed a good safety profile and clinically meaningful effects on physical function in a small clinical trial of three people with pulmonary arterial ... Read more

December 18, 2020December 18, 2020

Sotatercept Receives Orphan Drug Designation in Europe

News, PAH News

The European Commission has granted orphan drug designation to sotatercept for the treatment of people with pulmonary arterial hypertension (PAH). This designation is given to medications with the potential ... Read more

November 18, 2020November 20, 2020

Phase 2b Trial of Pemziviptadil, Peptide Treatment for PAH, Enrolling in US

News, PAH News

Enrollment is resuming for the VIP clinical trial, which is evaluating PhaseBio Pharmaceuticals‘ investigational therapy pemziviptadil (PB1046) in people with pulmonary arterial hypertension (PAH). The trial, which is recruiting adult ... Read more

November 16, 2020November 16, 2020

FDA Asked to Approve LungFit System to Treat Persistent PH in Newborns

News

Beyond Air filed an application with the U.S. Food and Drug Administration (FDA) requesting approval of its LungFit PH system — an investigational device used to deliver the vasodilator nitric ... Read more

November 6, 2020November 6, 2020

Research Project Seeks to Develop Voice-based Markers for Pulmonary Hypertension

News, PH News

Mayo Clinic and Vocalis Health announced a collaboration to research and develop new voice-based tools for screening, detecting, and monitoring health. The collaboration will begin with a project that seeks ... Read more

November 5, 2020November 5, 2020

NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits

News, syndicated

The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops in December, with the aim of empowering leaders to start non-profit ... Read more

October 23, 2020October 23, 2020

Tyvaso Improves Lung Function in PH-ILD Patients, New Trial Data Show

News, PH News

Treatment with Tyvaso (inhaled treprostinil) can improve lung function in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD), new data from a completed Phase 2/3 clinical trial show. These ... Read more

October 22, 2020October 22, 2020

Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say

News, syndicated

A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like the option of continuing its use in future appointments, a ... Read more

October 21, 2020October 21, 2020

Balloon Angioplasty May Help Considerably in Treating CTEPH, Study Finds

CTEPH News, News

The combination of pulmonary endarterectomy (PEA), a surgery to remove blood clots in the lungs, and balloon pulmonary angioplasty (BPA), the use of balloons to open narrowed or blocked ... Read more